Alpha Cognition Inc. Reports Fiscal 2025 Financial Results and Provides Operational Update

2026-03-26 - 20:20

VANCOUVER, British Columbia & GRAPEVINE, Texas -- Alpha Cognition Inc. (ACOG: NASDAQ) (“Alpha Cognition”, “ACI”, or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today reported financial results for the fourth quarter and full year ended December 31, 2025, and provided a business update. Read More